Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Neostigmine Infusion as Adjuvant Therapy in Sepsis and Septic Shock

NCT04130230 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT04130230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04130230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Neostigmine Infusion as Adjuvant Therapy in Sepsis and Septic Shock
Lead sponsor
Mansoura University
Phase
Phase 2
Overall status
Completed
Start date
March 6, 2019
Completion date
October 1, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock